Abbott Laboratories Stock Forecast for 2023 - 2025 - 2030

Updated on 05/27/2023

Stock Rating
10
Price Target
$125.00
Consensus
Outperform
Upside
21.51%
Analysts
15
Stock Rating
10
Upside
21.51%
Analysts
15
Price Target
$125.00

Abbott Laboratories Stock Forecast and Price Target

Abbott Laboratories's stock price reaches the average target of $125.00 by 2024 as expected recently by fiveteen notable experts, there would be a potential upside of approximately 21.51% from the last closing price in May, 2023. This possible increase is based on a high estimate of $140.00 and a low estimate of $104.00. If you are interested in ABT stock, it is important to also consider its competitors.

$125.00

21.51% Upside

Outperform
Outperform

Abbott Laboratories Fair Value Forecast for 2023 - 2025 - 2030

In the last three years, Abbott Laboratories's Price has grown by 23.77%, rising from $86.02 to $106.47. For next year, analysts predict Fair Value of $132.75, which would mean an increase of 24.69%. Over the next eight years, experts predict that Abbott Laboratories's Fair Value will grow at a rate of 59.87%.

2023 Fair Value Forecast
$132.75
2024 Fair Value Forecast
$146.82
2025 Fair Value Forecast
$161.96
2026 Fair Value Forecast
$176.56
2027 Fair Value Forecast
$181.07
2028 Fair Value Forecast
$168.94
2029 Fair Value Forecast
$166.92
2030 Fair Value Forecast
$170.21
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
ISRG Stock Forecast Intuitive Surgical Inc Outperform 13
$306.90 Buy/Sell $305.24 -8.11%
BSX Stock Forecast Boston Scientific Outperform 15
$51.06 Buy/Sell $52.51 -2.08%
DXCM Stock Forecast DexCom Outperform 16
$115.05 Buy/Sell $129.69 9.08%
RMD Stock Forecast ResMed Outperform 17
$215.44 Buy/Sell $251.67 17.20%
PODD Stock Forecast Insulet Outperform 15
$272.63 Buy/Sell $302.13 17.38%

Abbott Laboratories Revenue Forecast for 2023 - 2025 - 2030

In the last three years, Abbott Laboratories's Revenue has grown by 35.01%, rising from $31.90B to $43.08B. For the following year, the 23 analysts predict that Abbott Laboratories's Revenue will drop by 3.92%, reaching $41.39B. Over the next eight years, experts predict that Abbott Laboratories's Revenue will grow at a rate of 13.51%.

2023 Rev Forecast
$41.39B
2024 Rev Forecast
$44.20B
2025 Rev Forecast
$46.58B
2026 Rev Forecast
$49.65B
2027 Rev Forecast
$52.10B
2028 Rev Forecast
$49.32B
2029 Rev Forecast
$48.46B
2030 Rev Forecast
$48.89B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
NYSE:VAR Stock Forecast Varian Medical Systems - 16
$0.00 Buy/Sell $0.00 0.00%
MASI Stock Forecast Masimo Outperform 14
$157.35 Buy/Sell $166.14 8.04%
SWAV Stock Forecast ShockWave Medical Outperform 4
$280.67 Buy/Sell $0.00 -35.87%

Abbott Laboratories Dividend per Share Forecast for 2023 - 2025 - 2030

In the last three years, Abbott Laboratories's Dividend per Share has grown, rising from $1.32 to $2.04 – a growth of 54.55%. In the following year, the 10 analysts surveyed believe that Abbott Laboratories's Dividend per Share will decrease by 3.92%, reaching $1.96. For the next eight years, the forecast is for Dividend per Share to grow by 24.46%.

2023 DPS Forecast
$1.96
2024 DPS Forecast
$2.11
2025 DPS Forecast
$2.53
2026 DPS Forecast
$2.78
2027 DPS Forecast
$2.45
2028 DPS Forecast
$2.35
2029 DPS Forecast
$2.42
2030 DPS Forecast
$2.54
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
LVGO Stock Forecast Livongo Health - 0
$0.00 Buy/Sell $0.00 0.00%
INSP Stock Forecast Inspire Medical Systems Outperform 6
$294.29 Buy/Sell $0.00 1.94%
CMD Stock Forecast Cantel Medical - 17
$0.07 Buy/Sell $85.00 199600.00%

Abbott Laboratories Free Cash Flow Forecast for 2023 - 2025 - 2030

Abbott Laboratories's Free Cash Flow has seen impressive growth In the last three years, rising from $4.50B to $9.81B – a growth of 118.16%. According to the 6 analysts polled, in the next year, Abbott Laboratories's Free Cash Flow will fall by 12.74%, reaching $8.56B. For the next eight years, the forecast is for Free Cash Flow to grow by 11.77%.

2023 FCF Forecast
$8.56B
2024 FCF Forecast
$9.04B
2025 FCF Forecast
$9.48B
2026 FCF Forecast
$9.58B
2027 FCF Forecast
$13.70B
2028 FCF Forecast
$12.07B
2029 FCF Forecast
$11.36B
2030 FCF Forecast
$10.97B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
AXNX Stock Forecast Axonics Buy 7
$51.19 Buy/Sell $0.00 40.65%
IRTC Stock Forecast iRhythm Technologies Hold 11
$119.30 Buy/Sell $0.00 29.09%
CNMD Stock Forecast CONMED Outperform 16
$118.33 Buy/Sell $145.00 1.41%

Abbott Laboratories Net Income Forecast for 2023 - 2025 - 2030

Abbott Laboratories's Net Income has grown In the last three years, rising from $3.69B to $7.07B – a growth of 91.78%. In the next year, analysts believe that Net Income will reach $8.79B – an increase of 24.32%. For the next eight years, experts predict that Abbott Laboratories's Net Income will grow at a rate of 59.74%.

2023 NI Forecast
$8.79B
2024 NI Forecast
$9.75B
2025 NI Forecast
$10.69B
2026 NI Forecast
$11.74B
2027 NI Forecast
$12.03B
2028 NI Forecast
$11.22B
2029 NI Forecast
$11.07B
2030 NI Forecast
$11.30B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
TNDM Stock Forecast Tandem Diabetes Care Outperform 9
$26.57 Buy/Sell $127.93 246.26%
ITGR Stock Forecast Integer Holdings Buy 16
$80.37 Buy/Sell $111.33 35.62%
GNMK Stock Forecast GenMark Diagnostics - 2
$0.00 Buy/Sell $24.05 0.00%

Abbott Laboratories EBITDA Forecast for 2023 - 2025 - 2030

In the last three years, Abbott Laboratories's EBITDA has grown by 58.06%, rising from $7.77B to $12.28B. For the next year, 11 analysts project Abbott Laboratories's EBITDA to drop by 2.79%, reaching $11.94B. Over the next eight years, experts believe that Abbott Laboratories's EBITDA will grow at a rate of 5.59%.

2023 EBITDA Forecast
$11.94B
2024 EBITDA Forecast
$13.15B
2025 EBITDA Forecast
$12.29B
2026 EBITDA Forecast
$13.49B
2027 EBITDA Forecast
$12.71B
2028 EBITDA Forecast
$12.89B
2029 EBITDA Forecast
$12.71B
2030 EBITDA Forecast
$12.97B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
NVRO Stock Forecast Nevro Hold 6
$27.56 Buy/Sell $69.50 134.03%
SILK Stock Forecast Silk Road Medical, Inc Outperform 7
$30.65 Buy/Sell $0.00 69.66%
TMDX Stock Forecast TransMedics Group Outperform 8
$70.68 Buy/Sell $0.00 -60.38%

Abbott Laboratories EBIT Forecast for 2023 - 2025 - 2030

In the last two years, Abbott Laboratories's EBIT has grown, moving from $4.76B to $9.22B – an increase of 93.78%. In the next year, analysts predict that EBIT will jump to $10.32B – up 11.95% from the current level. Looking ahead to eight years, experts forecast that EBIT will grow by 43.17%.

2023 EBIT Forecast
$10.32B
2024 EBIT Forecast
$11.31B
2025 EBIT Forecast
$12.07B
2026 EBIT Forecast
$13.81B
2027 EBIT Forecast
$14.30B
2028 EBIT Forecast
$13.23B
2029 EBIT Forecast
$12.88B
2030 EBIT Forecast
$13.20B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
NTUS Stock Forecast Natus Medical - 14
$32.96 Buy/Sell $36.00 70.27%
CUTR Stock Forecast Cutera Buy 6
$16.64 Buy/Sell $42.20 368.75%
SENS Stock Forecast Senseonics Holdings Hold 6
$0.66 Buy/Sell $0.00 278.79%

Abbott Laboratories EPS Price Prediction Forecast for 2023 - 2025 - 2030

In the last three years, Abbott Laboratories's EPS has grown by 23.77%, rising from $3.24 to $4.01. For next year, analysts predict EPS of $5.00, which would mean an increase of 24.69%. Over the next eight years, experts predict that Abbott Laboratories's EPS will grow at a rate of 59.87%.

2023 EPS Forecast
$5.00
2024 EPS Forecast
$5.53
2025 EPS Forecast
$6.10
2026 EPS Forecast
$6.65
2027 EPS Forecast
$6.82
2028 EPS Forecast
$6.36
2029 EPS Forecast
$6.29
2030 EPS Forecast
$6.41
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
INGN Stock Forecast Inogen Outperform 8
$11.11 Buy/Sell $44.00 188.03%
QTRX Stock Forecast Quanterix Buy 11
$20.79 Buy/Sell $0.00 75.57%
VRAY Stock Forecast ViewRay Outperform 7
$0.53 Buy/Sell $0.00 1503.77%